https://stock.noler.com/us/stock/arcturus-therapeutics-ltd https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/accounts-payable https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/accounts-payable-and-other-accrued-liabilities-current https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/accounts-payable-related-parties-current https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/accounts-payable-trade-current https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/accounts-receivable https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/accrued-insurance-current https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/accrued-liabilities-current https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/accrued-royalties-current-and-noncurrent https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/accumulated-depreciation https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/acquired-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/additional-paid-in-capital https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/aoci https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/assets-fair-value-disclosure-recurring https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/assets-noncurrent https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/available-for-sale-amortized-cost https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/available-for-sale-current https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/available-for-sale-debt-current https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/available-for-sale-debt-securities https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/available-for-sale-gross-unrealized-loss https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/available-for-sale-securities https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/buybacks-treasury-stock-value-acquired-par-value-method https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/capital-expenditures https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/cash-and-equivalents https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/cash-and-restricted-cash https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/cash-flow-breakdown https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/common-dividends-paid https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/common-stock-value https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/comprehensive-income https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/contract-with-customer-asset-net https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/contract-with-customer-liability-change-in-timeframe-performance-obligation-satisfied-revenue-recognized https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/convertible-debt-current https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/convertible-notes-payable-current https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/cover-page-shares-outstanding https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/cumulative-effect-on-retained-earnings-tax https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/current-assets https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/current-liabilities https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/customer-refund-liability-current https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/debt-interest-rate https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/debt-issued https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/debt-maturing-in-year-four https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/debt-maturing-in-year-three https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/debt-maturing-in-year-two https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/deferred-revenue https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/deferred-revenue-noncurrent https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/deferred-tax-assets-gross https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/deferred-tax-assets-net https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/deferred-tax-assets-operating-loss-carryforwards-foreign https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/deposits-assets-noncurrent https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/depreciation https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/depreciation-and-amortization-expense https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/dividends-common-stock https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/effective-tax-rate https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/employee-benefits-and-share-based-compensation https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/employee-related-liabilities-current https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/equity-method-investment-ownership-percentage https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/equity-method-investments https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/financing-cash-flow https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/foreign-pretax-income https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/form-d-stocks https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/general-and-administrative-expense https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/goodwill-impairment-loss https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/government-contract-receivable https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/income-tax https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/income-taxes-paid https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/increase-decrease-in-accounts-payable-trade https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/increase-decrease-in-other-accounts-payable https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/induced-conversion-of-convertible-debt-expense https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/insider-transactions-stock-options https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/interest-expense https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/interest-expense-borrowings https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/interest-expense-long-term-debt https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/interest-expense-on-debt https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/interest-expense-other https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/interest-expense-related-party https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/interest-income-expense-net https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/interest-on-convertible-debt-net-of-tax https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/interest-paid https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/interest-paid-net https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/interest-receivable-current https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/investing-cash-flow https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/investment-income-interest https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/investment-income-interest-and-dividend https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/lease-and-rental-expense https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/long-term-debt https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/long-term-investments https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/long-term-purchase-commitment-amount https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/marketable-securities-current https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/maturities-of-available-for-sale-securities https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/maturities-of-shortterm-investments https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/minority-interest-ownership-percentage-by-noncontrolling-owners https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/net-cash-from-financing-activities https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/net-cash-from-investing-activities https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/net-cash-from-operating-activities https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/net-change-in-cash https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/net-income https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/noncash-or-part-noncash-acquisition-net-nonmonetary-assets-acquired-liabilities-assumed https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/noncash-or-part-noncash-acquisition-value-of-assets-acquired https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/noncash-or-part-noncash-acquisition-value-of-liabilities-assumed https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/number-of-operating-segments https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/oci-before-tax https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-cash-flow https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-expenses https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-income https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-lease-assets https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-lease-cost https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-lease-liability https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-lease-liability-current https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-lease-payments-due https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-lease-payments-due-2 https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-lease-payments-due-current https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-lease-payments-due-in-four-and-five-years https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-leases-income-statement-sublease-revenue https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-leases-rent-expense-net https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/operating-loss-carryforwards https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/other-accrued-liabilities-current https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/other-current-assets https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/other-liabilities https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/other-noncurrent-assets https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/other-noncurrent-liabilities https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/other-nonoperating-income-expense https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/payments-for-proceeds-from-short-term-investments https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/payments-to-acquire-restricted-investments https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/pre-opening-costs https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/prepaid-expense-current https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/pretax-income https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/pretax-income-domestic https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/proceeds-from-convertible-debt https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/proceeds-from-repayments-of-debt https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/proceeds-from-sale-of-available-for-sale-securities https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/proceeds-from-sale-of-restricted-investments https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/proceeds-from-stock-issued https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/professional-fees https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/property-plant-and-equipment-gross https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/property-plant-equipment https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/public-float https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/related-party-transaction-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/related-party-transaction-selling-general-and-administrative-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/research-and-development https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/restricted-cash https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/restricted-cash-current https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/restricted-cash-noncurrent https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/retained-earnings https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/revenue https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/revenue-from-grants https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/severance-costs https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/shareholders-equity https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/shares-authorized https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/shares-issued https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/short-term-investments https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-based-compensation https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-issued-new-shares-sold https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-issued-shares-issued-value-share-based-compensation-gross https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-options-exercisable-number https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-options-outstanding-number https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-options-vested-grant-date-fair-value https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/stock-split-ratio https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/tax-rate-reconciliation-tax-credits-other https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/tax-rate-reconciliation-tax-settlements https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/tax-reconciliation-other-reconciling-items https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/total-assets https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/total-contract-liability https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/total-liabilities https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/total-liabilities-and-equity https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/total-long-term-debt https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/treasury-stock-common-shares https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/treasury-stock-shares https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/treasury-stock-value https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/unrecognized-tax-benefits https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/arcturus-therapeutics-ltd/weighted-average-number-of-share-outstanding-basic-and-diluted